Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Cocrystal Pharma, Inc. (COCP) had Stock-Based Compensation of $0.08M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.23M |
|
$-2.30M |
|
-- |
|
$0.23M |
|
$2.58M |
|
$-2.36M |
|
$0.06M |
|
$-2.30M |
|
$-2.30M |
|
$-2.30M |
|
$-2.30M |
|
$-2.30M |
|
$-2.30M |
|
$-2.36M |
|
$-2.34M |
|
13.79M |
|
13.79M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$5.94M |
|
$0.08M |
|
$1.49M |
|
$7.43M |
|
$2.23M |
|
-- |
|
$1.08M |
|
$3.31M |
|
$4.12M |
|
$4.12M |
|
$4.12M |
|
13.79M |
|
| Cash Flow Statement Financials | |
$-2.34M |
|
-- |
|
-- |
|
$7.10M |
|
$4.76M |
|
$-2.34M |
|
|
Stock-Based Compensation |
$0.08M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.66 |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
100.00% |
|
-1047.11% |
|
-1047.11% |
|
-- |
|
-1021.78% |
|
-1021.78% |
|
$-2.34M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.30 |
|
304.40 |
|
-55.86% |
|
-55.86% |
|
-30.96% |
|
-55.86% |
|
$0.30 |
|
$-0.17 |
|
$-0.17 |
|